AKORN INC
Healthcare · Pharmaceutical Preparations · LA · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | |
|---|---|---|---|---|---|---|
| Revenue | $165.9M | $184.1M | $841.0M | $1.12B | $985.1M | $555.0M |
| Operating income | −$65.5M | −$25.4M | −$22.9M | $322.9M | $294.6M | $60.8M |
| Net income | −$82.2M | −$28.7M | −$24.6M | $184.2M | $150.8M | $13.9M |
| Total assets | $1.29B | $1.50B | $1.91B | $1.97B | $2.04B | $1.22B |
| Total liabilities | $1.05B | $1.05B | $1.08B | $1.15B | $1.42B | $929.2M |
| Equity | $234.3M | $443.9M | $831.2M | $819.2M | $621.6M | $356.3M |
| EPS (diluted) | $-0.65 | $-0.23 | $0.33 | $1.47 | $1.22 | $0.13 |
| Shares out. | 125.6M | 125.3M | 124.4M | 119.4M | 113.9M | 96.7M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2019- Operating margin
- −39.5%
- Net margin
- −49.5%
- Return on equity
- −35.1%
- Return on assets
- −6.4%
- Return on capital (ROCE)
- −21.6%
- Liabilities / assets
- 81.8%
- Debt / equity
- 4.50×
- Book value / share
- $1.87
- Revenue growth (YoY)
- −9.9%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2019- Altman Z″ (distress)
- -3.53distress
- Accruals / assets
- −3.5%clean
- Piotroski F-Score
- 2/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 5 warning● 1 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 10, 2016
- NT 10-Kmissed a reporting deadline ↗Feb 29, 2016
- NT 10-Qmissed a reporting deadline ↗Nov 9, 2015
- NT 10-Qmissed a reporting deadline ↗Aug 10, 2015
- NT 10-Qmissed a reporting deadline ↗May 8, 2015
- NT 10-Kmissed a reporting deadline ↗Mar 2, 2015
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Bankruptcy or receivership · Completed an acquisition or disposition · Modified shareholder rights · Change in control · Director / officer change · Other material eventOct 2, 2020
- Regulation FD disclosureSep 30, 2020
- Regulation FD disclosureSep 9, 2020
- Regulation FD disclosureAug 28, 2020
- Regulation FD disclosureAug 14, 2020
- Results of operationsAug 7, 2020
- Regulation FD disclosureJul 31, 2020
- Regulation FD disclosureJul 2, 2020
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/AFeb 10, 2021
- 15-12BFORM 15-12BOct 2, 2020
- S-8 POSOct 2, 2020
- S-8 POSOct 2, 2020
- S-8 POSOct 2, 2020
- S-8 POSOct 2, 2020
- S-8 POSOct 2, 2020
- S-8 POSOct 2, 2020
- S-8 POSOct 2, 2020
- S-8 POSOct 2, 2020
- S-8 POSOct 2, 2020
- S-8 POSOct 2, 2020
- S-8 POSOct 2, 2020
- 8-KFORM 8-KOct 2, 2020
- 8-KFORM 8-KSep 30, 2020
Event-driven situations (3)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.